Drug · DIN 02248968
FACTIVE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 19, 2009; first marketed November 24, 2006.
- Drug Identification Number (DIN)
- 02248968
- Company (DIN owner)
- Oscient Pharmaceuticals CorporationWaltham, Massachusetts, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Gemifloxacin J01MA15
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GEMIFLOXACIN (GEMIFLOXACIN MESYLATE) | 320 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 21, 2004: NOC 5413New Drug Submission (NDS) · Manufacturer name change
- March 9, 2004: NOC 90New Drug Submission (NDS)